| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | -$80K | — |
| R&D Expense | $15.5M | +969.2% |
| SG&A Expense | $67.9M | +430.7% |
| Operating Income | -$99.0M | -1707.2% |
| Net Income | -$12.1M | -121.7% |
| EPS (Basic) | -$0.06 | +100.0% |
| EPS (Diluted) | -$0.06 | +94.3% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $445.1M | +2497.3% |
| Accounts Receivable | $3.0M | — |
| Inventory | $20.9M | — |
| Current Assets | $496.1M | +118.8% |
| Total Assets | $530.3M | +133.8% |
| Current Liabilities | $31.3M | +516.2% |
| Total Liabilities | $160.2M | +1135.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$94.3M | -5634.7% |
| Capital Expenditures | $14.6M | +3278.2% |
| Investing Cash Flow | -$20.7M | +90.8% |
| Financing Cash Flow | $546.7M | +140.8% |
| Free Cash Flow | -$108.9M | -5145.3% |
| Stockholders' Equity |
| $374.8M |
| +7396.3% |